Cited by 201Mesenchymal stem cell researchExtracellular vesicles in diseasePeriodontal Regeneration and Treatments

Adipose-derived stem cells secretome and its potential application in “stem cell-free therapy”

Open access
Trzyna, Anna, Banaś-Ząbczyk, Agnieszka·2021·Biomolecules

Abstract

Adipose-derived stem cells (ASCs) secrete many cytokines, proteins, growth factors, and extracellular vesicles with beneficial outcomes that can be used in regenerative medicine. It has great potential, and the development of new treatment strategies using the ASCs secretome is of global interest. Besides cytokines, proteins, and growth factors, the therapeutic effect of secretome is hidden in non-coding RNAs such as miR-21, miR-24, and miR-26 carried via exosomes secreted by adequate cells. The whole secretome, including ASC-derived exosomes (ASC-exos) has been proven in many studies to have immunomodulatory, proangiogenic, neurotrophic, and epithelization activity and can potentially be used for neurodegenerative, cardiovascular, respiratory, inflammatory, and autoimmune diseases as well as wound healing treatment. Due to limitations in the use of stem cells in cell-based therapy, its secretome with emphasis on exosomes seems to be a reasonable and safer alternative with increased effectiveness and fewer side effects. Moreover, the great advantage of cell-free therapy is the possibility of biobanking the ASCs secretome. In this review, we focus on the current state of knowledge on the use of the ASCs secretome in stem cell-free therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom11060878

Cites

181 of 181 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MSC-derived exosomes have advantages over existing drugs or MSCs, including improved stability, limited immune rejection, convenient administration, and easy internalization into recipient cells.

    “When compared with existing drugs or mesenchymal stem cells (MSCs), MSC-derived exosomes generate distinct advantages and reduce side effects, such as improved stability, limited immune rejection, convenient administration, and easy internalization into recipient cells [15].”

    From Exosome-functionalized magnesium-organic framework-based scaffolds with osteogenic, angiogenic and anti-inflammatory properties for accelerated bone regeneration. (2022) · cites this paper as [15]

    Section 3.2 reports that adipose-derived MSC exosomes are stable in the body compared with whole cells and describes a reduced risk of tumorigenicity. It does not establish advantages over existing drugs or substantiate limited immune rejection, convenient administration, or easy internalization by recipient cells. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Trzyna, A., & Banaś-Ząbczyk, A.
Affiliations
University of Rzeszów (PL)
Corresponding author
Banaś-Ząbczyk, Agnieszka
Venue
Biomolecules
Publisher
MDPI AG
Published
2021-06-13
Volume
11
Issue
6
Pages
878
ISSN
2218-273X (ISSN-L)
OpenAlex
W3168570978
Cited by
201
References
181
Citations by year
2026: 32 · 2025: 38 · 2024: 47 · 2023: 38 · 2022: 37 · 2021: 9
FWCI
4.74
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Urology › Periodontal Regeneration and Treatments
Keywords
adipose-derived stem cells, secretome, exosomes, cell-free therapy, extracellular vesicles, microRNA, cytokines, growth factors, immunomodulation, angiogenesis, neurotrophic activity, wound healing, regenerative medicine, biobanking
MeSH terms
Adipose Tissue, Animals, Humans, Stem Cells, Adipocytes, Biological Specimen Banks, MicroRNAs, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review